Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride is mainly broken down by the enzyme CYP3A4, affecting its levels in the body.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

No link found between aromatase gene and female hair loss.

Four-amino acid part makes enzyme sensitive to finasteride.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain drugs that block specific enzymes can help treat prostate diseases.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Genetic screening can help diagnose and manage infertility in Slovenian couples.

Finasteride metabolism varies by age, sex, and P450 inducers, with males processing it faster.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Psychotropic drugs can interact with natural products, affecting their effectiveness and safety.

Phytoconstituents from Cyperus Rotundus may help treat hirsutism by interacting with the 5 α reductase enzyme.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Aromatase gene variation may increase female hair loss risk.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.